340 related articles for article (PubMed ID: 20601366)
21. Antigen as mediator of glomerular injury in experimental IgA nephropathy.
Montinaro V; Esparza AR; Cavallo T; Rifai A
Lab Invest; 1991 Apr; 64(4):508-19. PubMed ID: 2016857
[TBL] [Abstract][Full Text] [Related]
22. Effect of mizoribine on glomerulonephritis of early-stage IgA nephropathy in ddY mice.
Shimizu M; Shou I; Tsuge T; Abe M; Tomino Y
Nephron; 1998; 79(1):67-72. PubMed ID: 9609465
[TBL] [Abstract][Full Text] [Related]
23. Increased Serum IgA in Children with IgA Nephropathy, Severity of Kidney Biopsy Findings and Long-Term Outcomes.
Mizerska-Wasiak M; Małdyk J; Pańczyk-Tomaszewska M; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Firszt-Adamczyk A; Stankiewicz R; Bieniaś B; Zajączkowska M; Gadomska-Prokop K; Grenda R; Miklaszewska M; Pietrzyk J; Pukajło-Marczyk ; Zwolińska D; Szczepańska M; Demkow U; Roszkowska-Blaim M
Adv Exp Med Biol; 2015; 873():79-86. PubMed ID: 26269025
[TBL] [Abstract][Full Text] [Related]
24. Immunofluorescence deposits in the mesangial area and glomerular capillary loops did not affect the prognosis of immunoglobulin a nephropathy except C1q:a single-center retrospective study.
Wu L; Liu D; Xia M; Chen G; Liu Y; Zhu X; Liu H
BMC Nephrol; 2021 Jan; 22(1):43. PubMed ID: 33514328
[TBL] [Abstract][Full Text] [Related]
25. Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy.
Maeda I; Hayashi T; Sato KK; Shibata MO; Hamada M; Kishida M; Kitabayashi C; Morikawa T; Okada N; Okumura M; Konishi M; Konishi Y; Endo G; Imanishi M
Nephrol Dial Transplant; 2012 Jul; 27(7):2806-13. PubMed ID: 22492824
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy.
Wada Y; Ogata H; Takeshige Y; Takeshima A; Yoshida N; Yamamoto M; Ito H; Kinugasa E
Clin Exp Nephrol; 2013 Feb; 17(1):73-82. PubMed ID: 22752397
[TBL] [Abstract][Full Text] [Related]
27. Absence of mesangial C1q deposition is associated with resolution of proteinuria and hematuria after tonsillectomy plus steroid pulse therapy for immunoglobulin a nephropathy.
Nishiwaki H; Hasegawa T; Nagayama Y; Kaneshima N; Takayasu M; Hirose M; Komukai D; Inoue Y; Koiwa F; Yoshimura A
Nephron; 2015; 130(1):1-7. PubMed ID: 25896237
[TBL] [Abstract][Full Text] [Related]
28. IgA nephropathy with presentation of nephrotic syndrome at onset in children.
Shima Y; Nakanishi K; Sato M; Hama T; Mukaiyama H; Togawa H; Tanaka R; Nozu K; Sako M; Iijima K; Suzuki H; Yoshikawa N
Pediatr Nephrol; 2017 Mar; 32(3):457-465. PubMed ID: 27714465
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic findings relevant to disappearance or relapse of proteinuria following corticosteroid treatment in IgA nephropathy patients with proteinuria of 0.5 to 2.0 g/day.
Suzuki T; Yamamoto T; Ohura M; Fujigaki Y; Yonemura K; Kimura M; Hishida A
Clin Exp Nephrol; 2004 Sep; 8(3):243-9. PubMed ID: 15480902
[TBL] [Abstract][Full Text] [Related]
30. Prednisolone and azathioprine in IgA nephropathy - a ten-year follow-up study.
Goumenos DS; Davlouros P; El Nahas AM; Ahuja M; Shortland JR; Vlachojannis JG; Brown CB
Nephron Clin Pract; 2003; 93(2):C58-68. PubMed ID: 12616032
[TBL] [Abstract][Full Text] [Related]
31. Enzymolysis of glomerular immune deposits in vivo with dextranase/protease ameliorates proteinuria, hematuria, and mesangial proliferation in murine experimental IgA nephropathy.
Gesualdo L; Ricanati S; Hassan MO; Emancipator SN; Lamm ME
J Clin Invest; 1990 Sep; 86(3):715-22. PubMed ID: 2203821
[TBL] [Abstract][Full Text] [Related]
32. Validity of the Oxford classification of IgA nephropathy in children.
Shima Y; Nakanishi K; Hama T; Mukaiyama H; Togawa H; Hashimura Y; Kaito H; Sako M; Iijima K; Yoshikawa N
Pediatr Nephrol; 2012 May; 27(5):783-92. PubMed ID: 22134880
[TBL] [Abstract][Full Text] [Related]
33. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
McIntyre CW; Fluck RJ; Lambie SH
Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
[TBL] [Abstract][Full Text] [Related]
34. [Clinicopathologic features of membranous nephropathy coexisting with IgA nephropathy].
Wang SX; Zou WZ; Yang L; Zhao MH
Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):171-4. PubMed ID: 17535683
[TBL] [Abstract][Full Text] [Related]
35. Spatial arrangement of IgA and C3 as a prognostic indicator of IgA nephropathy.
Muda AO; Feriozzi S; Rahimi S; Faraggiana T
J Pathol; 1995 Oct; 177(2):201-8. PubMed ID: 7490687
[TBL] [Abstract][Full Text] [Related]
36. IgG deposits in the mesangium and capillary loops predict poor renal outcome in patients with IgA nephropathy: a single-center retrospective study.
Peng S; Lu W; Jiang X; Xu X; Wu Y
Ren Fail; 2020 Nov; 42(1):902-911. PubMed ID: 32869693
[TBL] [Abstract][Full Text] [Related]
37. Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort.
Bellur SS; Troyanov S; Cook HT; Roberts IS;
Nephrol Dial Transplant; 2011 Aug; 26(8):2533-6. PubMed ID: 21273233
[TBL] [Abstract][Full Text] [Related]
38. Use of mizoribine as a rescue drug for steroid-resistant pediatric IgA nephropathy.
Ikezumi Y; Suzuki T; Karasawa T; Kawachi H; Nikolic-Paterson DJ; Uchiyama M
Pediatr Nephrol; 2008 Apr; 23(4):645-50. PubMed ID: 18038158
[TBL] [Abstract][Full Text] [Related]
39. Glomerular morphology, natural history and treatment of children with IgA-IgG mesangial nephropathy.
McEnery PT; McAdams AJ; West CD
Perspect Nephrol Hypertens; 1973; 1 Pt 1():305-20. PubMed ID: 4620921
[No Abstract] [Full Text] [Related]
40. Glomerular electron-dense deposits in childhood IgA nephropathy.
Yoshikawa N; Ito H; Nakahara C; Yoshiara S; Yoshiya K; Matsuo T; Hasegawa O; Hazikano H; Okada S
Virchows Arch A Pathol Anat Histopathol; 1985; 406(1):33-43. PubMed ID: 3158115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
